Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxerol for Treatment of Nocturia
NCT02646826Phase 2Completed
- Sponsor
- Wellesley Pharmaceuticals
- Start
- Jan 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Paxerol in nocturia, sponsored by Wellesley Pharmaceuticals. Started Jan 2016; status: completed.
02
Drugs
Paxerol
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT02646826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646826.